Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca Lagnese

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Physical Review Letters|January 3, 2025
Detecting a Long-Lived False Vacuum with Quantum QuenchesGianluca Lagnese, Federica Maria Surace, Sid Morampudi, et al.
Frontiers in Immunology|December 22, 2025
Secondary antibody deficiencies: what's around the corner?Gianluca Lagnese, Carla Messuri, Remo Poto, et al.
Current Opinion in Allergy and Clinical Immunology|May 15, 2026
Vascular remodeling in asthma: from mechanisms to precision medicineRemo Poto, Rory Chan, Gianluca Lagnese, et al.
Current Opinion in Allergy and Clinical Immunology|June 4, 2025
Advancing precision medicine for asthma by focusing on type 2 cytokines and alarminsRemo Poto, Andrea Portacci, Rory Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2021
The immunology of switching biologics in severe eosinophilic asthma patientsGiuseppe Spadaro, Gianluca Lagnese, Alessandra Punziano, et al.
Rheumatology Advances in Practice|February 15, 2023
Adult-onset macrophage activation syndrome treated by interleukin-1 inhibitionFrancesca Della Casa, Angelica Petraroli, Ilaria Mormile, et al.
Frontiers in Immunology|October 16, 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)Remo Poto, Antonio Pecoraro, Anne Lise Ferrara, et al.
European Journal of Internal Medicine|September 27, 2025
Effectiveness of tezepelumab in severe asthma: A multicenter real-world studyRemo Poto, Gianluca Manganello, Antonio di Salvatore, et al.
Frontiers in Immunology|August 27, 2024
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cellsRemo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Frontiers in Immunology|October 23, 2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022Cinzia Milito, Federica Pulvirenti, Giulia Garzi, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Physical Review Letters|January 3, 2025
Detecting a Long-Lived False Vacuum with Quantum QuenchesGianluca Lagnese, Federica Maria Surace, Sid Morampudi, et al.
Frontiers in Immunology|December 22, 2025
Secondary antibody deficiencies: what's around the corner?Gianluca Lagnese, Carla Messuri, Remo Poto, et al.
Current Opinion in Allergy and Clinical Immunology|May 15, 2026
Vascular remodeling in asthma: from mechanisms to precision medicineRemo Poto, Rory Chan, Gianluca Lagnese, et al.
Current Opinion in Allergy and Clinical Immunology|June 4, 2025
Advancing precision medicine for asthma by focusing on type 2 cytokines and alarminsRemo Poto, Andrea Portacci, Rory Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2021
The immunology of switching biologics in severe eosinophilic asthma patientsGiuseppe Spadaro, Gianluca Lagnese, Alessandra Punziano, et al.
Rheumatology Advances in Practice|February 15, 2023
Adult-onset macrophage activation syndrome treated by interleukin-1 inhibitionFrancesca Della Casa, Angelica Petraroli, Ilaria Mormile, et al.
Frontiers in Immunology|October 16, 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)Remo Poto, Antonio Pecoraro, Anne Lise Ferrara, et al.
European Journal of Internal Medicine|September 27, 2025
Effectiveness of tezepelumab in severe asthma: A multicenter real-world studyRemo Poto, Gianluca Manganello, Antonio di Salvatore, et al.
Frontiers in Immunology|August 27, 2024
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cellsRemo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Frontiers in Immunology|October 23, 2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022Cinzia Milito, Federica Pulvirenti, Giulia Garzi, et al.
Pageof 3